Statistics for Acumen Pharmaceuticals, (id:8281 ABOS)
Valuation metrics
Market cap
142.39M
Enterprise value
-31,570,712.00
Trailing P/E (ttm)
-2.19
Forward P/E
-1.55
PEG ratio
-1.55
Price/Sales (ttm)
Price/Book (mrq)
0.66
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.34
Overview
Shares outstanding
60.08M
Float
32.42M
Shares short
1.45M
% Held by insiders
0.11%
% Held by institutions
0.78%
Average volume (10 days)
216.50K
Average volume (90 days)
Price summary
52-Week low
2.08
52-Week high
5.09
52-Week change
1.27%
Beta
0.04
50-Day moving average
2.61
200-Day moving average
3.06
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-20.99%
Return on equity
-32.83%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-92,838,000.00
Net income to common (ttm)
-81,672,000.00
Diluted EPS (ttm)
-1.38
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
200.34M
Total cash per share (mrq)
3.34
Total debt (mrq)
29.99M
Total Debt/Equity (mrq)
13.81
Current ratio (mrq)
1.04K%
Book value per share (mrq)
3.62
Cash flow
Cash flow statement
-67,314,000.00
Levered free cash flow (LFCF)
-41,690,752.00